1. Home
  2. VTYX vs WBI Comparison

VTYX vs WBI Comparison

Compare VTYX & WBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ventyx Biosciences Inc.

VTYX

Ventyx Biosciences Inc.

HOLD

Current Price

$13.95

Market Cap

990.9M

Sector

Health Care

ML Signal

HOLD

WBI

WaterBridge Infrastructure LLC Class A Shares Representing Limited Liability Company Interests

N/A

Current Price

$24.97

Market Cap

1.1B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
VTYX
WBI
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
990.9M
1.1B
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
VTYX
WBI
Price
$13.95
$24.97
Analyst Decision
Hold
Buy
Analyst Count
7
8
Target Price
$13.50
$27.25
AVG Volume (30 Days)
2.3M
538.4K
Earning Date
02-27-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$733,296,000.00
Revenue This Year
N/A
$21.70
Revenue Next Year
N/A
$12.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$18.64
52 Week High
$25.00
$27.12

Technical Indicators

Market Signals
Indicator
VTYX
WBI
Relative Strength Index (RSI) 72.03 65.59
Support Level $13.91 $21.46
Resistance Level $13.97 $25.54
Average True Range (ATR) 0.04 1.10
MACD -0.18 0.25
Stochastic Oscillator 54.55 82.48

Price Performance

Historical Comparison
VTYX
WBI

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About WBI WaterBridge Infrastructure LLC Class A Shares Representing Limited Liability Company Interests

WaterBridge Infrastructure LLC is integrated, pure-play water infrastructure company with operations predominantly in the Delaware Basin, the prolific oil and natural gas basin in North America. It operates the largest produced water infrastructure network in the United States through which it provides water management solutions to oil and natural gas E&P companies under long-term contracts, which include gathering, transporting, recycling and handling produced water. It also operate two energy waste management facilities for the disposal of non-hazardous waste resulting from oil and gas E&P activities, branded under Desert Environmental. The transportation, treatment and handling of produced water is crucial to oil and natural gas production.

Share on Social Networks: